Articles |
24th November 2022
| 3 mins read
Learning to manage the risks involved in high potency drugs manufacturing
Mark Arnold, MD of ONFAB, describes the challenges in handling HPAPIs and how pharma manufacturers can learn to manage the risk involved.
1
2
3